Pathstone Family Office’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,184
Closed -$49K – 905
2020
Q4
$49K Hold
1,184
– – ﹤0.01% 517
2020
Q3
$50K Hold
1,184
– – 0.01% 370
2020
Q2
$51K Hold
1,184
– – 0.01% 315
2020
Q1
$39K Hold
1,184
– – 0.01% 340
2019
Q4
$43.6K Hold
1,184
– – ﹤0.01% 316
2019
Q3
$40K Hold
1,184
– – 0.01% 302
2019
Q2
$47K Hold
1,184
– – 0.01% 335
2019
Q1
$48K Buy
+1,184
New +$44.1K 0.01% 311
2018
Q4
– Sell
-60
Closed -$3K – 539
2018
Q3
$3K Buy
+60
New +$3K ﹤0.01% 203
2017
Q3
– Sell
-761
Closed -$37K – 231
2017
Q2
$37K Buy
+761
New +$35K 0.02% 221

Other funds holding FMS

Pathstone Family Office's FMS Position: Q1 2021 in Review

Pathstone Family Office sold out of Fresenius Medical Care (FMS) in Q1 2021, closing a stake of 1,184 shares — an estimated $49K sold.

Pathstone Family Office first reported a position in FMS in Q2 2017 and held it in 10 quarters. The position peaked at $51K in Q2 2020. 167 funds tracked by Wall St. Rank hold FMS as of Q1 2021.

  • Pathstone Family Office reported no remaining Fresenius Medical Care position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 1,184 Fresenius Medical Care shares in Q1 2021, an estimated $49K.
  • Pathstone Family Office first reported a position in Fresenius Medical Care in Q2 2017 and held it in 10 quarters.
  • Pathstone Family Office's Fresenius Medical Care position peaked at $51K in Q2 2020.
  • 167 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.